BioLife Solutions (BLFS) Tops Q3 EPS by 4c, Beats on Revenue; Offers FY24 Revenue Guidance
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $26.10 -1.88%
EPS Growth %: +109.1%
Financial Fact:
Amortization of deferred financing costs: 0
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +109.1%
Financial Fact:
Amortization of deferred financing costs: 0
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $30.57 million versus the consensus estimate of $25.54 million.
GUIDANCE:
BioLife Solutions sees FY2024 revenue of $98-100 million, versus the consensus of $110.6 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Circle board member resigns after nearly 13 years of service
- Nutrien warns shareholders about below-market mini-tender offer
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
